| CAS NO: | 1438851-35-4 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 生物活性 | ABP 215 (Bevacizumab-awwb), a Bevacizumab (Bevacizumab (HY-P9906)) biosimilar, is a humanizedIgG1monoclonal antibody targetingVEGFA(VEGFR). ABP 215 has anticancer effects, and can be used metastatic colorectalcancer(mCRC) research[1][2]. |
| 体外研究 (In Vitro) | ABP 215 (Bevacizumab-awwb) 与 VEGF-A 结合，阻止 VEGF-A 与内皮细胞表面的 VEGF 受体结合，抑制内皮细胞增殖和新血管形成，从而导致肿瘤脉管系统正常化。 |
| CAS 号 | 1438851-35-4 |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com